CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: immunotherapy trial shows promise
Disease control Recruiting nowThis study tests pembrolizumab, an immunotherapy that helps the immune system fight cancer, in children aged 6 months to 18 years with advanced melanoma, solid tumors, or lymphoma that has spread, returned, or not responded to treatment. The goal is to see if the drug can shrink …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New drug combo aims to cut radiation for young hodgkin patients
Disease control Recruiting nowThis study tests whether replacing two standard chemotherapy drugs with brentuximab vedotin can help more children and young adults (ages 2 to 34) with newly diagnosed Hodgkin lymphoma achieve a complete response early in treatment. The goal is to reduce the need for radiation th…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for tough blood cancers: first human trial of MGD024 begins
Disease control Recruiting nowThis early-stage study tests a new drug called MGD024 in about 130 adults with certain blood cancers (like leukemia or lymphoma) that did not get better with standard treatments or came back. The main goal is to find a safe dose and understand side effects. Participants receive t…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Lifestyle makeover for lymphoma survivors: a new hope for better living?
Symptom relief Recruiting nowThis study tests whether a personalized healthy lifestyle plan can improve quality of life for people who have survived certain types of lymphoma. It involves 552 adults aged 18-50 who have been in remission for 3 to 10 years. Participants will either receive the lifestyle plan o…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: NA • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Blood test may predict hodgkin relapse in kids
Knowledge-focused Recruiting nowThis study looks at whether a blood test that detects tumor DNA can help doctors better predict if Hodgkin lymphoma will come back in children and young adults under 25. Researchers will follow 400 participants over several years to see how well the test works compared to standar…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 05:33 UTC